ijms-logo

Journal Browser

Journal Browser

Cytokines: Biological Effects and Therapeutic Uses

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Biochemistry".

Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 5651

Special Issue Editors


E-Mail
Guest Editor
Medical Clinic and Policlinic III, University Hospital Bonn, Bonn, Germany
Interests: immunotherapy; gene therapy; Wnt pathway; multiple myeloma; pancreatic carcinoma

Special Issue Information

Dear Colleagues,

Cytokines, such as interleukin and interferon, are endogenous signaling molecules that are often secreted as part of an immune response. They play a major role in a variety of biological activities as immunomodulating agents by mediating humoral and cell-based immune responses and regulate cell repair, growth, and remodelling. In a number of studies, it was shown that an excessive as well as an insufficient production of cytokines can contribute to the rise of different diseases, including cancer. The restoration of an optimal cytokine balance is of utmost therapeutic value and has been examined in a number of clinical studies. The systemic administration of different cytokines in a setting of different cancers showed significant effects, even though severe side effects were observed. Nevertheless, more data and clinical experience have still to be acquired to find out if adjuvant cytokine treatment can safely be used in cancer patients.

This Special Issue will cover a selection of recent research topics in the field of cytokines, focusing on their biological effects and therapeutic uses. Experimental papers, up-to-date review articles, and commentaries are all welcome.

Dr. Young Kim
Prof. Dr. Ingo Schmidt-Wolf
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cytokines
  • cancer therapy
  • cellular therapy
  • CIK cells
  • immunotherapy
  • immunomodulation
  • immune response
  • immune system
  • interferon
  • interleukin
  • NKT cells
  • tumor vaccination
  • vaccination therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 4358 KiB  
Article
Transgenic Silkworm-Based Silk Gland Bioreactor for Large Scale Production of Bioactive Human Platelet-Derived Growth Factor (PDGF-BB) in Silk Cocoons
by Wenjing Chen, Feng Wang, Chi Tian, Yuancheng Wang, Sheng Xu, Riyuan Wang, Kai Hou, Ping Zhao, Ling Yu, Zhisong Lu and Qingyou Xia
Int. J. Mol. Sci. 2018, 19(9), 2533; https://doi.org/10.3390/ijms19092533 - 27 Aug 2018
Cited by 24 | Viewed by 5034
Abstract
Human platelet derived growth factor (PDGF) is a major therapeutic protein with great demand in the clinical setting; however, its rate of supply is far from meeting needs. Here, we provide an effective strategy to produce PDGF-BB in large quantities using a transgenic [...] Read more.
Human platelet derived growth factor (PDGF) is a major therapeutic protein with great demand in the clinical setting; however, its rate of supply is far from meeting needs. Here, we provide an effective strategy to produce PDGF-BB in large quantities using a transgenic silkworm. The codon-optimized PDGF-B gene regulated by the highly efficient sericin-1 expression system was integrated into the genome of a silkworm. The high transcriptional expression of the PDGF-BB gene in the transgenic silkworm competitively inhibited the transcription expression of the endogenous sericin-1 gene which caused a significant 37.5% decline. The PDGF-BB synthesized in the middle silk gland (MSG) of transgenic silkworms could form a homodimer through intermolecular disulfide bonds, which is then secreted into sericin lumen and finally, distributed in the sericin layer of the cocoon. In this study, a protein quantity of approximately 0.33 mg/g was found in the cocoon. Following a purification process, approximately 150.7 μg of recombinant PDGF-BB with a purity of 82% was purified from 1 g of cocoons. Furthermore, the bioactivity assays showed that the purified recombinant PDGF-BB was able to promote the growth, proliferation and migration of NIH/3T3 cells significantly. These results suggest that the silk gland bioreactor can produce active recombinant PDGF-BB as an efficient mitogen and wound healing agent. Full article
(This article belongs to the Special Issue Cytokines: Biological Effects and Therapeutic Uses)
Show Figures

Graphical abstract

Back to TopTop